Free Trial
NASDAQ:IVA

Inventiva (IVA) Stock Price, News & Analysis

Inventiva logo
$5.67 +0.41 (+7.79%)
As of 12:06 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Inventiva Stock (NASDAQ:IVA)

Key Stats

Today's Range
$5.54
$5.80
50-Day Range
$2.98
$6.35
52-Week Range
$1.53
$6.50
Volume
49,840 shs
Average Volume
22,210 shs
Market Capitalization
$542.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.83
Consensus Rating
Moderate Buy

Company Overview

Inventiva Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
54th Percentile Overall Score

IVA MarketRank™: 

Inventiva scored higher than 54% of companies evaluated by MarketBeat, and ranked 539th out of 941 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Inventiva has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Inventiva has only been the subject of 3 research reports in the past 90 days.

  • Read more about Inventiva's stock forecast and price target.
  • Percentage of Shares Shorted

    0.03% of the outstanding shares of Inventiva have been sold short.
  • Short Interest Ratio / Days to Cover

    Inventiva has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Inventiva has recently increased by 188.00%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Inventiva does not currently pay a dividend.

  • Dividend Growth

    Inventiva does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.03% of the outstanding shares of Inventiva have been sold short.
  • Short Interest Ratio / Days to Cover

    Inventiva has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Inventiva has recently increased by 188.00%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Inventiva has a news sentiment score of 0.37. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.96 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 14 news articles for Inventiva this week, compared to 2 articles on an average week.
  • Search Interest

    4 people have searched for IVA on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Inventiva to their MarketBeat watchlist in the last 30 days. This is a decrease of -80% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Inventiva insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    32.00% of the stock of Inventiva is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 19.06% of the stock of Inventiva is held by institutions.

  • Read more about Inventiva's insider trading history.
Receive IVA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inventiva and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IVA Stock News Headlines

Washington prepares for war
While the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much bigger here at home. Emergency powers are being invoked, trillions are being mobilized, and the scale rivals anything we’ve seen since WWII. According to Porter Stansberry and Jeff Brown, a new economic arms race is already underway — one that could reshape markets, redirect capital, and impact billions of lives. They’ve just released an urgent briefing that explains what’s really happening behind the scenes, and which companies are positioned to benefit most.tc pixel
Piper Sandler Begins Coverage on Inventiva (NASDAQ:IVA)
See More Headlines

IVA Stock Analysis - Frequently Asked Questions

Inventiva's stock was trading at $2.14 at the start of the year. Since then, IVA shares have increased by 164.5% and is now trading at $5.66.

Inventiva (IVA) raised $103 million in an initial public offering (IPO) on Friday, July 10th 2020. The company issued 7,500,000 shares at a price of $13.68 per share. Jefferies, Stifel and Guggenheim Securities served as the underwriters for the IPO and H.C. Wainwright, Roth Capital Partners and KBC Securities were co-managers.

Top institutional investors of Inventiva include Wealth Enhancement Advisory Services LLC (0.02%) and Creative Planning (0.01%).

Shares of IVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Inventiva investors own include Kinross Gold (KGC), Oncobiologics (OTLK), Accuray (ARAY), Carnival (CCL), Alibaba Group (BABA), PayPal (PYPL).

Company Calendar

Today
9/03/2025
Next Earnings (Estimated)
9/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:IVA
CIK
1756594
Fax
N/A
Employees
100
Year Founded
2011

Price Target and Rating

High Price Target
$26.00
Low Price Target
$3.00
Potential Upside/Downside
+159.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.92
Quick Ratio
0.92

Sales & Book Value

Annual Sales
$9.95 million
Price / Sales
50.57
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.21) per share
Price / Book
-4.35

Miscellaneous

Outstanding Shares
95,660,000
Free Float
65,050,000
Market Cap
$503.17 million
Optionable
Not Optionable
Beta
0.69

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:IVA) was last updated on 9/3/2025 by MarketBeat.com Staff
From Our Partners